Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management?
The current treatment paradigm for prolactinomas involves dopamine agonist (DA) therapy as the first-line treatment, with surgical resection reserved for cases where there is DA failure due to resistance or intolerance. This review hig hlights how DA therapy can be optimised to overcome its increasi...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bioscientifica
2023-01-01
|
| Series: | Endocrine Oncology |
| Subjects: | |
| Online Access: | https://eo.bioscientifica.com/view/journals/eo/2/1/EO-21-0038.xml |